LUNDEMOSE ANKER MD, PH.D, DSC 4
4 · OSI PHARMACEUTICALS INC · Filed Dec 15, 2009
Insider Transaction Report
Form 4
LUNDEMOSE ANKER MD, PH.D, DSC
Exec. VP & Pres. OSI Prosidion
Transactions
- Tax Payment
Common Stock
2009-12-12$34.75/sh−892$30,997→ 26,687 total - Tax Payment
Common Stock
2009-12-13$34.75/sh−815$28,321→ 25,872 total
Footnotes (1)
- [F1]Reflects the withholding of shares by the Company to satisfy the tax liability upon the vesting of Restricted Stock Units.